07/02/2026
The Department of Microbiology & Lab Medicine, Indus International Hospital, successfully conducted an academic CME on “Point of Care to Precision Testing”, STI Panel, with a special emphasis on the expanding role of IHC marker panels in oncopathology diagnosis.
The sessions highlighted how advanced molecular diagnostics, comprehensive STI panels, and an expanded IHC marker repertoire are transforming disease detection enabling more accurate tumor classification, prognostication, and personalized treatment planning in modern oncopathology. The discussion reinforced the shift from conventional testing toward precision-driven, evidence-based diagnostics.
We thank all speakers and participants for their enthusiastic involvement, making this CME an enriching academic experience focused on innovation, accuracy, and improved patient outcomes.